GlassScriptPhysician profile
Navid Ahmed
NPI 1659727048
$10,761.61
in general payments reported to CMS, 2019-2025
35 companies · $2,562 in 2025
The $2,562 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.41 · 2022: $3,286 · 2023: $1,422 · 2024: $3,459 · 2025: $2,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,423 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,423.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,604.74 | 2022-2024 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Merlin@Home |
| Amgen INC. | $919.90 | 2022-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $907.05 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $665.06 | 2023-2025 | Verquvo, Capvaxive, Gardasil |
| Novartis Pharmaceuticals Corporation | $484.06 | 2022-2025 | |
| Novo Nordisk INC | $476.03 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $412.37 | 2023-2024 | Xarelto |
| Lilly USA, LLC | $318.62 | 2022-2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $286.91 | 2024-2025 | Watchman Flx, General - Therapies |
| Astrazeneca Pharmaceuticals LP | $278.81 | 2025 | Farxiga, Wainua, Lokelma |
| Pfizer INC. | $267.15 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.71 | 2022-2025 | Jardiance |
| Medtronic, INC. | $224.11 | 2024 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Scpharmaceuticals INC. | $203.61 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $169.88 | 2022-2023 | Acuson Redwood Diagnostic Ultrasound System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $149.28 | 2025 | Paradise Ultrasound Renal Denervation System |
| Sanofi-Aventis U.S. LLC | $143.80 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $128.63 | 2024-2025 | Evkeeza |
| Exact Sciences Corporation | $107.49 | 2023-2024 | Cologuard Collection Kit |
| Kiniksa Pharmaceuticals International, Plc | $96.94 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $95.87 | 2023-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $76.91 | 2025 | |
| Astellas Pharma US INC | $74.75 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $73.92 | 2023 | Arcalyst |
| Shield Therapeutics INC | $73.66 | 2025 | |
| Inspire Medical Systems, INC. | $41.96 | 2025 | Inspire |
| Philips North America LLC | $41.15 | 2025 | Mcot, Laser Parts Other |
| Chiesi USA, INC. | $40.51 | 2022-2025 | Kengreal, Cleviprex |
| Cvrx, INC. | $37.72 | 2024 | Barostim Neo System |
| Tactile Systems Technology INC | $26.31 | 2025 | Nimbl, Flexitouch Plus |
| Medicomp INC | $21.68 | 2025 | Telepatch Cardiac Monitor |
| Medicure Pharma INC. | $20.50 | 2024 | Zypitamag |
| Dexcom, INC. | $18.38 | 2023 | Dexcom G6 Transmitter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.01 | 2022 | |
| Abbvie INC. | $17.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.